• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3360.0
  • ISIN : INE198H01019
102.52 0 (0.15%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    101.10

  • Today’s High

    103.99

  • Open

    102.37

  • Perv Close

    102.37

  • 52W Low

    50.31

  • 52W High

    103.99

Key Indicators

  • P/E(TTM)

    75.96

  • Mar.Cap (₹Cr.)

    316.52

  • Div & Yield %

    0.00

  • Book Value(₹)

    53.90

  • Debt-Equity Ratio

    0.15

  • AGM Date

    22-Sep-2026

  • EPS

    1.35

  • P/E Ratio

    75.96

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    316.52

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    30.87

  • BV (₹)

    53.90

  • Sales( ₹ in Cr.)

    472.27

  • NP (in Cr.)

    3.97

  • NP Var(%)

    -1.0

  • Div%

    0.0

  • CPS (₹)

    2.20

  • EPS (₹)

    1.30

  • Traded Value (₹ in Lakhs)

    316.62

  • 52 Week High

    103.99

  • 52 Week Low

    50.31

  • Price BSE

    103.0

  • Price NSE

    103.00

  • Market Capital( in Cr.)

    316.62

  • P/C Ratio

    46.60

  • P/E Ratio

    80.20

  • Price Vs.BV

    1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 473.94 395.62 418.96 492.76 348.42 300.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 473.94 395.62 418.96 492.76 348.42 300.09
Other Income 9.81 6.96 2.73 2.67 7.01 6.69
Stock Adjustments 10.80 5.86 15.14 -4.77 1.46 -4.25
Total Income 494.55 408.44 436.83 490.66 356.89 302.53
EXPENDITURE :            
Raw Materials 472.87 387.76 418.98 461.35 335.96 285.93
Power and Fuel Cost 0.05 0.03 0.03 0.04 0.00 0.01
Employee Cost 0.62 0.54 0.63 0.67 0.20 0.29
Other Manufacturing Expenses 1.96 0.76 1.50 7.15 4.99 1.31
Selling and Administration Expenses 6.24 7.68 4.52 6.89 3.88 4.94
Miscellaneous Expenses 0.11 0.26 0.71 0.50 0.20 0.12
Employee Benefit Expenses 0.62 0.54 0.63 0.67 0.20 0.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 481.85 397.03 426.37 476.60 345.23 292.61
Operating Profit 12.71 11.42 10.45 14.07 11.66 9.93
Interest 4.66 4.38 2.87 2.04 2.44 1.79
Gross Profit 8.05 7.04 7.58 12.03 9.22 8.14
Depreciation 1.94 1.70 1.57 1.99 0.92 0.89
Profit Before Tax 6.11 5.34 6.01 10.04 8.30 7.25
Current Tax 1.91 1.33 2.28 3.59 1.66 1.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.17 -0.67 -0.04 -0.11 0.12 -0.05
Reported Net Profit 4.02 4.68 3.77 6.55 6.51 5.79
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 4.02 4.68 3.77 6.55 6.51 5.79
Adjustment below Net Profit 0.00 0.00 0.00 -0.01 0.00 0.00
P & L Balance brought forward 53.11 48.42 44.65 38.11 31.59 25.80
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 57.13 53.11 48.42 44.65 38.11 31.59
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.41 1.67 1.49 2.58 2.79 2.48
Earnings Per Share(Adj)-Unit Curr 1.41 1.67 1.49 2.58 2.79 2.48
Book Value 46.90 45.57 44.43 43.85 41.29 38.50
Book Value(Adj)-Unit Curr 46.90 45.57 44.43 43.85 41.29 38.50

Shareholding Pattern

  • Promoter Group

    42.79%

  • Public Share Holding

    57.21%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,010,000 6.51 2,010,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,202,443 36.28 11,202,443 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,212,443 42.79 13,212,443 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,362,317 4.41 1,362,317 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 459,667 1.49 459,667 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,821,984 5.90 1,821,984 5
2] Non Institution
Bodies Corporate 2,887,894 9.35 2,866,414 86
Clearing Members 336,526 1.09 336,526 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 99,338 0.32 99,338 79
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 523,560 1.70 523,560 184
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,405,796 23.99 7,405,796 95
Individuals holding nominal share capital up to Rs. 1 lakh 4,407,641 14.28 3,919,042 13,002
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,839,876 51.30 15,329,797 13,467
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 30,874,303 100.00 30,364,224 13,480

Company Background

Aarey Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarey Drugs & Pharmaceuticals Ltd
  • BSE Code : 3360.0
  • ISIN : INE198H01019

  • Incorporation Year

    1990

  • Registered Office

    E-34 MIDC Tarapur
    Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-23455543

  • FAX

  • Chairman

    Mihir R Ghatalia

  • Managing Director

    Mihir R Ghatalia

  • Company Secretary

    KAILASH CHAND JETHLIA

  • Auditor

    Motilal & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarey Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarey Drugs 102.55 483.76 473.94 75.96 6.38
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77